Does ivabradine balance dobutamine effects in cardiogenic shock? A promising new strategy
Acta Physiol (Oxf)
.
2016 Oct;218(2):73-7.
doi: 10.1111/apha.12733.
Epub 2016 Jul 8.
Authors
M Akodad
1
2
,
P Lim
3
,
F Roubille
4
5
Affiliations
1
Cardiology Department, University Hospital of Montpellier, Montpellier, France.
2
PhyMedExp, INSERM U1046, CNRS UMR 9214, University of Montpellier, Montpellier Cedex 5, France.
3
Cardiology Intensive Care, University Hospital Henri Mondor, Créteil, France.
4
Cardiology Department, University Hospital of Montpellier, Montpellier, France. francois.roubille@gmail.com.
5
PhyMedExp, INSERM U1046, CNRS UMR 9214, University of Montpellier, Montpellier Cedex 5, France. francois.roubille@gmail.com.
PMID:
27291979
DOI:
10.1111/apha.12733
No abstract available
Publication types
Editorial
Comment
MeSH terms
Benzazepines
Dobutamine*
Humans
Ivabradine
Shock, Cardiogenic*
Substances
Benzazepines
Ivabradine
Dobutamine